| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise? | 7 | Zacks | ||
| INTUITIVE SURGICAL INC CDR Aktie jetzt für 0€ handeln | |||||
| Di | Intuitive Surgical: Bewertungsabschlag ohne Bruch der Investment-Story - Chance für geduldige Qualitätsanleger? | 531 | ARIVA.de | Intuitive Surgical bleibt operativ auf Kurs, während die Bewertung nachgibt. Trotz temporärer Belastungen durch Nachholeffekte aus der Pandemie und makroökonomische Unsicherheiten sieht Seeking Alpha... ► Artikel lesen | |
| 02.10. | Can ISRG Offset China Weakness With Expansion in India and Japan? | 27 | Zacks | ||
| 01.10. | Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer. | 32 | The Motley Fool | ||
| 30.09. | What You Need To Know Ahead of Intuitive Surgical's Earnings Release | 19 | Barchart.com | ||
| 28.09. | Gilead vs. Intuitive Surgical: Which Healthcare Stock Offers the Better Risk-Adjusted Upside? | 30 | Insider Monkey | ||
| 24.09. | Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting? | 22 | The Motley Fool | ||
| 14.09. | Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition? | 30 | Zacks | ||
| 14.09. | INTUITIVE SURGICAL NORDICS: Intuitive advances da Vinci 5 innovations in Europe | 14 | Cision News | ||
| 12.09. | $1000 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today | 11 | Benzinga.com | ||
| 09.09. | Intuitive Surgical auf Wells-Fargo-Konferenz: Wachstum verlangsamt sich, Ausblick bestätigt | 46 | Investing.com Deutsch | ||
| 09.09. | ISRG Stock Trading at its Cheapest in 10 Years: Should You Buy Now? | 26 | Zacks | ||
| 08.09. | Intuitive Surgical: Studie belegt Vorteile von Da-Vinci-Operationen | 55 | Investing.com Deutsch | ||
| 08.09. | Intuitive Surgical, Inc.: New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions | 17 | GlobeNewswire (USA) | ||
| 07.09. | ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine | 51 | Zacks | ||
| 07.09. | Intuitive Surgical (ISRG): Embracing AI Innovations in Robotic Surgery for Future Growth | 23 | Insider Monkey | ||
| 05.09. | Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning? | 39 | The Motley Fool | ||
| 02.09. | Intuitive Surgical's Worst Stretch in Years Isn't Scaring Wall Street -- Here's What Analysts Are Focused On Instead | 39 | The Motley Fool | ||
| 01.09. | How Is Intuitive Surgical's Stock Performance Compared to Other Health Care Equipment Stocks? | 4 | Barchart.com | ||
| 01.09. | Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds? | 23 | Zacks |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 370,25 | -0,11 % | Intuitive Surgical: Bewertungsabschlag ohne Bruch der Investment-Story - Chance für geduldige Qualitätsanleger? | Intuitive Surgical bleibt operativ auf Kurs, während die Bewertung nachgibt. Trotz temporärer Belastungen durch Nachholeffekte aus der Pandemie und makroökonomische Unsicherheiten sieht Seeking Alpha... ► Artikel lesen | |
| ADAPTHEALTH | 6,065 | 0,00 % | Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big Swings | OTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,65 | 0,00 % | BMO Capital reiterates Outperform on BrightSpring Health stock | ||
| ALIGNMENT HEALTHCARE | 8,720 | +0,11 % | William Blair stuft Alignment Healthcare wegen Kostendruck und Rating-Herabstufung ab | ||
| HEARTFLOW | 47,590 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| BILLIONTOONE | 95,41 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| FRESENIUS | 42,420 | +2,00 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Fresenius vor einem Treffen mit dem Chef Michael Sen auf "Buy" mit einem Kursziel von 55 Euro belassen. Die geschäftliche... ► Artikel lesen | |
| PROGYNY | 27,820 | -0,04 % | Progyny expects 1.2 million new covered lives in 2027 | ||
| FRESENIUS MEDICAL CARE | 37,480 | +2,07 % | Fresenius Medical Care Aktie: Wechsel an der Konzernspitze | Fresenius Medical Care bekommt kurzfristig einen neuen Vorstandschef. Shervin J. Korangy übernimmt mit Wirkung zum 12. Oktober 2026 den Vorsitz des Vorstands. Der Aufsichtsrat hat die Personalie am... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,235 | 0,00 % | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | ||
| PRIVIA HEALTH GROUP | 20,180 | 0,00 % | Privia Health Group, Inc.: Privia Health to Report Third Quarter 2026 Results on Thursday, November 5 | ||
| GENEDX | 67,67 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| LIFESTANCE HEALTH GROUP | 12,060 | 0,00 % | Transcript: LifeStance Health Gr Q2 2026 Earnings Conference Call | ||
| BETA BIONICS | 17,440 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| CONCENTRA GROUP | 36,670 | 0,00 % | Why Concentra's Quiet Healthcare Business Keeps Winning |